Many people with high blood pressure know they could be at risk for stroke and heart attack. However, too many people, still struggle to get their blood pressure under control.

Now a new risk of high blood pressure is emerging: the connection between uncontrolled blood pressure and dementia. Important new studies link high blood pressure, especially in midlife, to an increased risk for dementia later on.

On Wednesday, October 19 at 7:00 PM ET, the National Institute of Neurological Disorders and Stroke (NINDS), together with Morehouse College, will host a webinar on this important health topic. During “How Black Men Can Prevent Stroke & Dementia Later in Life: An Open Dialogue with Alumni & Students,” NINDS and Morehouse College will discuss the link between blood pressure, stroke, and dementia and the higher risks for Black men ages 28-45. The virtual event, which is free and open to the public, will also feature personal stories from alumni, helpful resources from the NINDS’ Mind Your Risks® campaign, and provide an opportunity to ask questions and engage with experts.

Special Guest include Director of the Office of Global Health and Health Disparities in the NINDS Division of Clinical Research, Dr. Richard Benson, Morehouse College Director of Alumni Engagement, Partnerships, and Events, Sean Bland, and former Dean of Students and Morehouse College Alumnus Alvin Darden

RSVP for the webinar here.

NINDS is the nation’s leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit